Filter Specialty
Filterspecialty
Submit To The Journals

EUROPEAN OPHTHALMIC REVIEW – VOLUME 7 ISSUE 2 – WINTER 2013

Welcome to the winter edition of the European Ophthalmic Review, which contains interesting updates in cornea and glaucoma as well as a multitude of reviews in hot retinal topics, including AMD and DMO treatments. The main outcomes given at the European Society of Ophthalmology (SOE) 2013 Symposium on ocular surface damages exerted by chemical preservatives contained in anti-glaucoma eyedrops have also been included, as well as another discussing the challenges in the management of DMO. The articles will certainly meet the interest of readers as they cover many specific topics concerning practice, science and technology. Please peruse and enjoy the expert content and we welcome any feedback you may have.

Foreword

Foreword – European Ophthalmic Review, 2013;7(2):68

Foreword – European Ophthalmic Review, 2013;7(2):68

Cornea

Evaluation of Corneal Vessels

Evaluation of Corneal Vessels

Glaucoma

The Role of Preservative-free Therapies in the Treatment of Glaucoma

The Role of Preservative-free Therapies in the Treatment of Glaucoma

Retina

Anti–vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularisation

Anti–vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularisation

Current Ophthalmic Management for Retinal Vein Occlusion

Current Ophthalmic Management for Retinal Vein Occlusion

Psychophysical Exams as Early Indicators of Diabetic Retinopathy

Psychophysical Exams as Early Indicators of Diabetic Retinopathy

Microstructural Changes in Central Serous Chorioretinopathy Documented by Spectral-domain Optical Coherence Tomography

Microstructural Changes in Central Serous Chorioretinopathy Documented by Spectral-domain Optical Coherence Tomography

Age-related Macular Degeneration

Ranibizumab in Treatment for Age-related Macular Degeneration

Ranibizumab in Treatment for Age-related Macular Degeneration

Diabetic Macular Oedema

Management of Diabetic Macular Oedema – Challenges and Solutions Along the Patient Journey

Management of Diabetic Macular Oedema – Challenges and Solutions Along the Patient Journey

Intravitreal ILUVIEN® Implant for Diabetic Macular Oedema – Early Case Experiences

Intravitreal ILUVIEN® Implant for Diabetic Macular Oedema – Early Case Experiences

ILUVIEN® Intravitreales Implantat bei diabetischem Makulaödem – Erste Fallstudien

ILUVIEN® Intravitreales Implantat bei diabetischem Makulaödem – Erste Fallstudien

Navigated Laser Therapy for Diabetic Macular Oedema

Navigated Laser Therapy for Diabetic Macular Oedema

  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchOphthalmology is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.